Trial Parameters
Brief Summary
This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. The study will clarify whether the implementation (compliance) and overall satisfaction of the patient are better with follow-up by a headache nurse compared to standard follow-up. Patients with signed written consent will be randomised to either group a: Telephone calls from nurse after two and 6 week or B. Patient-initiated follow-up by their general practitioner.
Eligibility Criteria
Inclusion Criteria: * One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua * Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness. Exclusion Criteria: * Uncertain headache diagnosis. * Need further investigation after the initial consultation. * Lack of understanding of information provided in Norwegian, both verbally and in writing. * Inability to keep a digital headache diary. * Need treatment of other comorbid conditions requiring follow-up in specialized healthcare. * Treatment with Onabotulinumtoxin A or Calcitonin-gene-related Peptide (CGRP) inhibitors given with three months intervals